63 related articles for article (PubMed ID: 27803599)
1. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma.
Hirte H; Yao X; Ferguson SE; May T; Elit L
Curr Oncol; 2021 Mar; 28(2):1114-1124. PubMed ID: 33804587
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
5. Conscious sedation guidance.
Coulthard P
Evid Based Dent; 2006; 7(4):90-1. PubMed ID: 17187034
[TBL] [Abstract][Full Text] [Related]
6. Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer.
Cohen PA; Webb PM; King M; Obermair A; Gebski V; Butow P; Morton R; Lawson W; Yates P; Campbell R; Meniawy T; McMullen M; Dean A; Goh J; McNally O; Mileshkin L; Beale P; Beach R; Hill J; Dixon C; Hegarty S; Codde J; Ives A; Lee YC; Brand A; Mellon A; Bilic S; Black I; Jeffares S; Friedlander M
Int J Gynecol Cancer; 2022 Apr; 32(4):560-565. PubMed ID: 34551895
[TBL] [Abstract][Full Text] [Related]
7. Follow-up Care for Survivors of Prostate Cancer - Clinical Management: a Program in Evidence-Based Care Systematic Review and Clinical Practice Guideline.
Loblaw A; Souter LH; Canil C; Breau RH; Haider M; Jamnicky L; Morash R; Surchin M; Matthew A
Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):711-717. PubMed ID: 28928084
[TBL] [Abstract][Full Text] [Related]
8. Systemic therapy for recurrent epithelial ovarian cancer: a clinical practice guideline.
Francis J; Coakley N; Elit L; Mackay H;
Curr Oncol; 2017 Dec; 24(6):e540-e546. PubMed ID: 29270064
[TBL] [Abstract][Full Text] [Related]
9. Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update.
Elit L; Kennedy EB; Fyles A; Metser U
Curr Oncol; 2016 Apr; 23(2):109-18. PubMed ID: 27122975
[TBL] [Abstract][Full Text] [Related]
10. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract][Full Text] [Related]
11. A study to evaluate the use of CA125 in ovarian cancer follow-up: A change in practice led by patient preference.
Palmer C; Pratt J; Basu B; Earl H
Gynecol Oncol; 2006 Apr; 101(1):4-11. PubMed ID: 16445969
[TBL] [Abstract][Full Text] [Related]
12. Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline.
Elit L; Zitzelsberger L; Fung-Kee-Fung M; Brouwers M; Graham ID; Browman G; Hoskins P; Lau S; Ghatage P;
Gynecol Oncol; 2007 Jul; 106(1):181-92. PubMed ID: 17498781
[TBL] [Abstract][Full Text] [Related]
13. Follow-up for women after treatment for cervical cancer.
Elit L; Fyles AW; Oliver TK; Devries-Aboud MC; Fung-Kee-Fung M;
Curr Oncol; 2010 Jun; 17(3):65-9. PubMed ID: 20567627
[TBL] [Abstract][Full Text] [Related]
14. Exercise for people with cancer: a clinical practice guideline.
Segal R; Zwaal C; Green E; Tomasone JR; Loblaw A; Petrella T;
Curr Oncol; 2017 Feb; 24(1):40-46. PubMed ID: 28270724
[TBL] [Abstract][Full Text] [Related]
15. An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Surveillance Strategies in Patients with Stage I, II, III or Resectable IV Melanoma Who Were Treated with Curative Intent.
Rajagopal S; Yao X; Abadir W; Baetz TD; Easson AM; Knight G; McWhirter E; Nessim C; Rosen CF; Sun A; Wright FC; Petrella TM
Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):243-253. PubMed ID: 38336503
[TBL] [Abstract][Full Text] [Related]
16. Treatment and follow-up strategies in desmoid tumours: a practice guideline.
Ghert M; Yao X; Corbett T; Gupta AA; Kandel RA; Verma S; Werier J
Curr Oncol; 2014 Aug; 21(4):e642-9. PubMed ID: 25089635
[TBL] [Abstract][Full Text] [Related]
17. British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice.
Fotopoulou C; Hall M; Cruickshank D; Gabra H; Ganesan R; Hughes C; Kehoe S; Ledermann J; Morrison J; Naik R; Rolland P; Sundar S
Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():123-139. PubMed ID: 28457647
[No Abstract] [Full Text] [Related]
18. Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment.
Zachou G; El-Khouly F; Dilley J
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD006119. PubMed ID: 37650760
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of patients who are clinically disease-free after primary treatment for fallopian tube, primary peritoneal, or epithelial ovarian cancer: a Program in Evidence-Based Care guideline adaptation.
Le T; Kennedy EB; Dodge J; Elit L
Curr Oncol; 2016 Oct; 23(5):343-350. PubMed ID: 27803599
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
